Immunohistochemical analysis of the IL‐6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Interleukin‐6 (IL‐6) and its receptor have been implicated in prostate cancer progression. Because other members of the IL‐6 family such as leukaemia inhibitory factor (LIF) and oncostatin M (OSM) share gp130, the signal transduction subunit of their receptors, interpretation of the data without considering the expression of these cytokines and their specific receptor subunits could be misleading. The immunohistochemical pattern of the IL‐6 family and their receptor subunits in normal prostate, benign prostatic hyperplasia (BPH), and prostatic carcinoma (PC) was investigated. In normal prostates, gp130 and OSMRα were detected exclusively in the stroma and LIFRβ was very scarce. While IL‐6 was scarcely immunolocalized to the basal cells of the epithelium, OSM was detected in the stroma and LIF in both the epithelium and the stroma. This suggests an autocrine role for this family of cytokines in the stroma of normal prostates. In BPH, gp130 and OSMRα were detected both in the epithelium and in the stroma, whereas LIFRβ was localized only to the epithelium. IL‐6 localized preferentially to the epithelium, OSM to the stroma, and LIF to both compartments. Therefore, in addition to the autocrine role in the stroma, IL‐6 and OSM may play a paracrine role from the stroma to the epithelium in BPH. In PC, gp130 and OSMRα were detected both in the epithelium and in the stroma, increasing with rising Gleason grade, whereas LIFRβ was localized exclusively to the epithelium of low Gleason grade carcinomas. IL‐6, LIF, and OSM localized in all cell types, with immunostaining increasing with Gleason grade. These data suggest an autocrine role for these cytokines in the epithelial cells of PC. The distinct pattern of expression of LIFRβ exclusively in low Gleason grade carcinomas makes LIFRβ a candidate for malignancy diagnosis. The role of OSM mainly in high Gleason grade carcinomas makes OSM a putative target for prostate cancer therapy. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Shariat, S. F., Andrews, B., Kattan, M. W., Kim, J., Wheeler, T. M., & Slawin, K. M. (2001) · Urology · doi:10.1016/s0090-4295(01)01405-4 · Cited by 261
Cited by
Giannoni, E., Bianchini, F., Masieri, L., Serni, S., Torre, E., Calorini, L., & Chiarugi, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0785 · Cited by 596
Evolution of cooperation among tumor cells
Axelrod, R., Axelrod, D. E., & Pienta, K. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606053103 · Cited by 436
Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer
Morgan, E. T., Goralski, K. B., Piquette-Miller, M., Renton, K. W., Robertson, G. R., Chaluvadi, M. R., Charles, K. A., Clarke, S. J., Kacevska, M., Liddle, C., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018747 · Cited by 395
Interleukin-6 regulation of prostate cancer cell growth.
Culig, Z., Steiner, H., Bartsch, G., & Hobisch, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20477 · Cited by 269
Cancer Stem Cell Plasticity Drives Therapeutic Resistance
Doherty, M., Smigiel, J., Junk, D., & Jackson, M. (2016) · Cancers · doi:10.3390/cancers8010008 · Cited by 160
“Elevated levels of OSM in the TME are associated with highly aggressive metastatic cancers and an increased risk of tumor recurrence (chemotherapy resistance) in a variety of tumor types [61,63–83].”
Background
Metadata
- Authors
- Royuela, M., Ricote, M., Parsons, M. S., García‐Tuñón, I., Paniagua, R., & De Miguel, M. P.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2003-11-27
- Volume
- 202
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W1969888008
- Cited by
- 110
- References
- 2
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.